STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,376 | -66.2% | 3,291 | -23.5% | 0.00% | -75.0% |
| Q1 2022 | $90,000 | +172.7% | 4,300 | +207.1% | 0.01% | +166.7% |
| Q4 2021 | $33,000 | +10.0% | 1,400 | +16.7% | 0.00% | +50.0% |
| Q3 2021 | $30,000 | +400.0% | 1,200 | +500.0% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $7,000 | -41.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +100.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |